SEC Form 4 · accession 0001209191-17-062841
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry A. George
Director
Period of report
Nov 27, 2017
Accepted (ET)
Nov 29, 2017 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 27, 2017 | A | 7,500 | $2.21 | A | 22,500 | D | |
| Common StockF1 | Nov 28, 2017 | A | 7,500 | $2.19 | A | 30,000 | D | |
| Common StockF2 | holding | — | — | — | 144,366 | I | By Entities affiliated with Solstice Capital |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were acquired by the Reporting Person pursuant to the Issuer's Amended and Restated Stock Purchase Plan adopted December 1, 2015, as amended January 21, 2016.
- F2The Reporting Person is the managing member of Solstice Capital and has joint voting and investment power over the shares held by Solstice Capital.